Literature DB >> 2203531

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.

M Kieran1, V Blank, F Logeat, J Vandekerckhove, F Lottspeich, O Le Bail, M B Urban, P Kourilsky, P A Baeuerle, A Israël.   

Abstract

The major determinant in the transcriptional control of class I genes of the major histocompatibility complex is an enhancer sequence located around -170 from the transcription start site, which binds a factor named KBF1. We have isolated a complementary cDNA coding for KBF1 and identified the DNA binding and dimerization domain of the protein. Because KBF1 and the transcription factor NF-kappa B bind to similar sequences, we investigated the relationship between these two molecules. It appeared that KBF1 is, by all criteria used, identical to the 50 kd DNA binding subunit of NF-kappa B. KBF1 (and therefore p50) also displays extensive amino acid sequence homology with the v-rel oncogene and the Drosophila maternal morphogen dorsal. In vitro experiments suggest functional homologies between KBF1 and v-rel.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203531     DOI: 10.1016/0092-8674(90)90275-j

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  310 in total

Review 1.  Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.

Authors:  R T Hay; L Vuillard; J M Desterro; M S Rodriguez
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Characterization of Chlamydomonas reinhardtii zygote-specific cDNAs that encode novel proteins containing ankyrin repeats and WW domains.

Authors:  H Kuriyama; H Takano; L Suzuki; H Uchida; S Kawano; H Kuroiwa; T Kuroiwa
Journal:  Plant Physiol       Date:  1999-03       Impact factor: 8.340

Review 3.  One path to cell death in the nervous system.

Authors:  J Glasgow; R Perez-Polo
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

4.  Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element.

Authors:  A L Lattion; E Espel; P Reichenbach; C Fromental; P Bucher; A Israël; P Baeuerle; N R Rice; M Nabholz
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  In vivo self-association of the Drosophila rel-protein dorsal.

Authors:  S Govind; A M Whalen; R Steward
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.

Authors:  Sergey A Trushin; Kevin N Pennington; Eva M Carmona; Susana Asin; Doris N Savoy; Daniel D Billadeau; Carlos V Paya
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Alternate RNA splicing of murine nfkb1 generates a nuclear isoform of the p50 precursor NF-kappa B1 that can function as a transactivator of NF-kappa B-regulated transcription.

Authors:  R J Grumont; J Fecondo; S Gerondakis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Viral induction of the human beta interferon promoter: modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors.

Authors:  E Garoufalis; I Kwan; R Lin; A Mustafa; N Pepin; A Roulston; J Lacoste; J Hiscott
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.